On June 23, 2025, Celularity Inc. entered a securities purchase agreement to sell 739,286 shares of its Class A common stock at $1.40 per share, aiming to raise approximately $1,035,000 for working capital. Additionally, the exercise price of certain investors' existing warrants was adjusted to $2.50 per share, extending their expiration to June 30, 2030.